• Product NameClindamycin HCl
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityClindamycin HCl inhibits protein synthesis by acting on the 50S ribosomal, used for the treatment of bacterial infections.
• Target NameOthers inhibitor
• CAS No. 21462-39-5
• Calculated MW 461.44
• Formulation C18H33ClN2O5S.HCl
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:Cl.CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H](C(C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O |r|
  Pathways:Others
  Receptor:Others
  Boling pt:
  Melting pt:
  Solubility:DMSO:92 mg/mL (199.37 mM)Ethanol:<1 mg/mL (<1 mM)Water:92 mg/mL (199.37 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Batzias GC, et al. Vet J, 2005, 170(3), 339-345.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting